Abstract The US Food and Drug Administration approval of the first 3D printed tablet in 2015
has ignited growing interest in 3D printing, or additive manufacturing (AM), for drug delivery …

Organ-on-a-chip technology tries to mimic the complexity of native tissues in vitro. Important
progress has recently been made in using this technology to study the gut with and without …

Organ-on-a-chip (OOAC) is an emerging technology based on microfluid platforms and in
vitro cell culture that has a promising future in the healthcare industry. The numerous …

Spinal cord injury (SCI) is a serious problem that primarily affects younger and middle-aged
adults at its onset. To date, no effective regenerative treatment has been developed. Over …

Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging,
microsurgery procedures, and microscale technologies have made minimally invasive …

New emerging technologies, remarkably miniaturized 3D organ models and microfluidics,
enable simulation of the real in vitro microenvironment ex vivo more closely. There are many …

Advances in nanotechnology are impacting biomedicine with the potential to improve
disease diagnosis, enhance targeted drug delivery, refine imaging of therapeutic responses …

Microphysiological systems, also known as organ‐on‐a‐chip platforms, show promise for
the development of new testing methods that can be more accurate than both conventional …

Low back pain is the leading cause of disability worldwide and in many patients the source
of pain can be attributed to pathological changes within the intervertebral disc (IVD). As …

A comprehensive understanding of the complex physiological and pathological processes
associated with alveolar bones, their responses to different therapeutics strategies, and cell …